CI · Cigna Group - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $68.49B | - | $69.75B | $67.18B | $65.50B | - | $63.69B | $60.52B | $57.26B | - |
| Cost of Revenue | $54.10B | - | $55.53B | $53.27B | $48.40B | - | $47.56B | $44.49B | $41.43B | - |
| Gross Profit | $14.39B | - | $14.22B | $13.91B | $17.10B | - | $16.13B | $16.03B | $15.82B | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $3.72B | - | $3.36B | $3.43B | $4.21B | - | $3.59B | $3.68B | $3.71B | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $650.00M | - | $650.00M | $738.00M | $674.00M | - | - | - | $741.00M | - |
| Operating Income | $2.36B | - | $2.58B | $2.31B | $1.97B | - | $2.58B | $2.41B | $2.26B | - |
| Interest Expense | $357.00M | - | $363.00M | $338.00M | $362.00M | - | $380.00M | $378.00M | $369.00M | - |
| Income Tax | $409.00M | - | $322.00M | $389.00M | $239.00M | - | $367.00M | $360.00M | $291.00M | - |
| Net Income | $1.32B | - | $1.87B | $1.53B | $1.32B | - | $739.00M | $1.55B | ($277.00M) | - |
| EPS - Basic | $6.30 | - | $7.02 | $5.76 | $4.88 | - | $2.65 | $5.51 | ($0.97) | - |
| EPS - Diluted | $6.26 | - | $6.98 | $5.71 | $4.85 | - | $2.63 | $5.45 | ($0.97) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | $7.82B |
| Accounts Receivable | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | $17.72B |
| Inventory | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | $5.64B |
| Accounts Payable | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | $8.55B |
| Current Assets | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | $37.35B |
| Total Assets | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | $152.76B |
| Current Liabilities | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | $48.72B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | $106.41B |
| Stockholders' Equity | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | $46.22B |
| Retained Earnings | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | $41.65B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.13B | - | - | - | $1.92B | - | - | - | $4.84B | - |
| Investing Cash Flow | ($637.00M) | - | - | - | $1.20B | - | - | - | ($495.00M) | - |
| Financing Cash Flow | ($1.14B) | - | - | - | ($3.68B) | - | - | - | ($2.53B) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 21.0% | - | 20.4% | 20.7% | 26.1% | - | 25.3% | 26.5% | 27.6% | - |
| Operating margin | 3.4% | - | 3.7% | 3.4% | 3.0% | - | 4.0% | 4.0% | 3.9% | - |
| EBITDA margin | 4.4% | - | 4.6% | 4.5% | 4.0% | - | - | - | 5.2% | - |
| Net margin | 1.9% | - | 2.7% | 2.3% | 2.0% | - | 1.2% | 2.6% | -0.5% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 5.4% | - | 4.8% | 5.1% | 6.4% | - | 5.6% | 6.1% | 6.5% | - |
| Effective tax rate | 23.6% | - | 14.7% | 20.2% | 15.3% | - | 33.2% | 18.9% | 2078.6% | - |
| Return on assets | 0.9% | - | 1.2% | 1.0% | 0.9% | - | 0.5% | 1.0% | -0.2% | - |
| Return on equity | 3.1% | - | 4.5% | 3.8% | 3.3% | - | 1.8% | 3.7% | -0.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.82 | 0.85 | 0.83 | 0.79 | 0.78 | 0.84 | 0.86 | 0.83 | 0.83 | 0.77 |
| Quick ratio | 0.71 | 0.72 | 0.73 | 0.68 | 0.69 | 0.73 | 0.77 | 0.74 | 0.75 | 0.65 |
| Cash ratio | 0.13 | 0.14 | 0.11 | 0.08 | 0.15 | 0.13 | 0.10 | 0.12 | 0.16 | 0.16 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 6.6x | - | 7.1x | 6.8x | 5.4x | - | 6.8x | 6.4x | 6.1x | - |
| Equity multiplier | 3.63 | 3.79 | 3.78 | 3.77 | 3.75 | 3.80 | 3.74 | 3.76 | 3.72 | 3.30 |
| Liabilities / Assets | 0.72 | 0.73 | 0.73 | 0.73 | 0.73 | 0.74 | 0.73 | 0.73 | 0.73 | 0.70 |
| Efficiency | ||||||||||
| Asset turnover | 0.45 | - | 0.44 | 0.44 | 0.43 | - | 0.40 | 0.39 | 0.37 | - |
| Inventory turnover | 9.28 | - | 9.86 | 8.93 | 9.35 | - | 9.36 | 8.60 | 8.95 | - |
| Days sales outstanding | 142d | - | 166d | 169d | 150d | - | 160d | 151d | 131d | - |
| Days inventory outstanding | 39d | - | 37d | 41d | 39d | - | 39d | 42d | 41d | - |
| Days payable outstanding | 67d | - | 61d | 68d | 69d | - | 65d | 76d | 72d | - |
| Cash conversion cycle | 114d | - | 142d | 142d | 120d | - | 133d | 118d | 100d | - |
| Valuation | ||||||||||
| P / E | 42.6x | - | 41.3x | 57.9x | 67.8x | - | 131.7x | 60.7x | - | - |
| P / B | 1.7x | - | 1.8x | 2.2x | 2.2x | - | 2.3x | 2.3x | 2.5x | - |
| P / S | 1.0x | - | 1.1x | 1.3x | 1.4x | - | 1.5x | 1.6x | 1.8x | - |
| EV / EBITDA | 21.1x | - | 22.0x | 27.7x | 30.8x | - | - | - | 31.9x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 4.6% | - | 9.5% | 11.0% | 14.4% | - | 29.9% | 24.6% | 23.1% | - |
| Revenue CAGR (3y) | 13.8% | - | 15.5% | 13.9% | 14.2% | - | 12.9% | 12.0% | 11.8% | - |
| Revenue CAGR (5y) | 10.8% | - | 11.2% | 11.3% | 11.2% | - | 10.6% | 9.3% | 8.6% | - |
| Gross profit growth (YoY) | -15.8% | - | -11.8% | -13.2% | 8.1% | - | 4.7% | 5.9% | 5.1% | - |
| Operating income growth (YoY) | 19.6% | - | 0.1% | -4.4% | -12.6% | - | 15.0% | 8.6% | 12.0% | - |
| Net income growth (YoY) | 0.0% | - | 152.8% | -1.0% | - | - | -47.5% | 6.0% | - | - |
| EPS growth (YoY) | 29.1% | - | 165.4% | 4.8% | - | - | -44.5% | 10.8% | - | - |
| EPS CAGR (3y) | 13.9% | - | -8.0% | 5.2% | 9.6% | - | -18.2% | 8.6% | - | - |
| EPS CAGR (5y) | 13.7% | - | 13.1% | 3.8% | 9.0% | - | -5.9% | 8.1% | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 4.9% | 1.7% | -0.7% | -2.7% | -2.3% | -11.2% | -7.9% | -9.1% | -7.5% | 3.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$283.04B totalEvernorth$234.95B · 83.0%
Cigna Healthcare$47.41B · 16.8%
All Other Segments$674.00M · 0.2%
Product / service
$469.10B totalProduct$216.67B · 46.2%
Network Pharmacy$125.57B · 26.8%
Home Delivery And Specialty$80.49B · 17.2%
Service$16.92B · 3.6%
Service Fees And Other Revenues$15.42B · 3.3%
Other Pharmacy$13.33B · 2.8%
Service Other$696.00M · 0.1%
Peer comparison
Same SIC group: Hospital & Medical Service Plans
Comparing Cigna Group against the 5 most active filers in the same SIC group.
Dividends
$4.58/share trailing 12 months · -21.3% YoY
| Ex-date | Per share |
|---|---|
| Mar 5, 2026 | $1.5600 |
| Dec 4, 2025 | $1.5100 |
| Sep 4, 2025 | $1.5100 |
| Jun 3, 2025 | $1.5100 |
| Mar 5, 2025 | $1.5100 |
| Dec 4, 2024 | $1.4000 |
| Sep 4, 2024 | $1.4000 |
| Jun 4, 2024 | $1.4000 |
| Mar 5, 2024 | $1.4000 |
| Dec 5, 2023 | $1.2300 |
| Sep 5, 2023 | $1.2300 |
| Jun 6, 2023 | $1.2300 |
| Mar 7, 2023 | $1.2300 |
| Dec 5, 2022 | $1.1200 |
| Sep 6, 2022 | $1.1200 |
| Jun 7, 2022 | $1.1200 |
| Mar 8, 2022 | $1.1200 |
| Dec 6, 2021 | $1.0000 |
| Sep 7, 2021 | $1.0000 |
| Jun 7, 2021 | $1.0000 |
| Mar 9, 2021 | $1.0000 |
| Mar 9, 2020 | $0.0400 |
| Mar 8, 2019 | $0.0400 |
| Mar 9, 2018 | $0.0400 |